About Global Congress on Advanced Vaccine Research and Biotechnology

Elevate Your Career — Attend the Conference to Secure Your CPD Credits

The Global Congress on Advanced Vaccine Research and Biotechnology, scheduled for June 15–16, 2026 in Paris, France, serves as an international platform to explore the next era of vaccine science and biotechnology. This congress brings together leading researchers, clinicians, biotechnologists, pharmaceutical experts, and policymakers to share cutting-edge advancements and address the pressing challenges of global immunization and health security.

VaxCon 2026 will cover a wide spectrum of themes, including mRNA technologies, synthetic biology, novel adjuvants, cancer immunotherapy, nanotechnology in vaccine delivery, AI-driven vaccine design, and pandemic preparedness. Through keynote lectures, panel discussions, workshops, and networking sessions, participants will engage in cross-disciplinary dialogue that fosters collaboration between academia, industry, and public health organizations.

Paris, often celebrated as the “City of Light,” is not only a hub of culture and history but also a global leader in hosting world-class conferences. With its advanced convention facilities, seamless international connectivity, and strong network of academic and research institutions, Paris provides the ideal environment for fostering innovation, collaboration, and scientific exchange. Hosting the Global Congress on Advanced Vaccine Research and Biotechnology here ensures accessibility for participants worldwide while situating discussions in a city renowned for intellectual and cultural influence. Beyond the professional setting, Paris offers an unforgettable experience for visitors. This unique blend of professional excellence and cultural richness makes Paris the perfect destination to combine scientific advancement with memorable travel experiences.

Vision & Purpose

The vision of the congress is to accelerate innovation in vaccine research and biotechnology to create a healthier, safer world. By uniting diverse stakeholders, the event aims to transform scientific discoveries into accessible solutions that directly impact global health outcomes.

The purpose of this gathering is not only to showcase breakthroughs but also to inspire partnerships, address ethical and regulatory considerations, and advance equitable healthcare solutions. With a focus on innovation, resilience, and inclusivity, the congress aspires to build a global community committed to strengthening vaccine development and biotechnological progress for the benefit of all.

Why It Matters

As the world continues to face emerging infectious diseases, antimicrobial resistance, and global health disparities, vaccines remain one of the most powerful tools in safeguarding humanity. Biotechnology is unlocking new frontiers—from mRNA platforms and nanotechnology to synthetic biology—offering breakthroughs not only in prevention but also in personalized and therapeutic vaccines. This congress addresses these timely challenges, uniting pioneers from across the globe to accelerate discoveries that can transform healthcare for generations.

What to Expect

Over two days in Paris, attendees will engage in plenary sessions, keynote addresses, interactive panels, and hands-on workshops. The program features cutting-edge topics such as AI in vaccine design, rapid response platforms for pandemics, cancer immunotherapies, and next-generation delivery systems. Beyond sessions, the congress creates a vibrant space for networking, research collaborations, and industry partnerships, with opportunities to connect academia, biotech start-ups, and global health organizations.

 Who Should Attend

• Vaccine Researchers & Immunologists
• Biotech & Pharma Industry Leaders
• Public Health Experts & Policy Makers
• Clinicians, Microbiologists & Infectious Disease Specialists
• Start-ups, Investors & Innovation Hubs

 Impact & Takeaway

The Global Congress on Advanced Vaccine Research and Biotechnology is not just a scientific meeting—it is a platform for driving change and innovation in global health. By combining visionary science with real-world application, the event ensures that every participant leaves with new insights, collaborations, and solutions to advance vaccine development and biotechnology worldwide.